A detailed history of Cidel Asset Management Inc transactions in Zoetis Inc. stock. As of the latest transaction made, Cidel Asset Management Inc holds 116,318 shares of ZTS stock, worth $20.4 Million. This represents 1.79% of its overall portfolio holdings.

Number of Shares
116,318
Previous 134,398 13.45%
Holding current value
$20.4 Million
Previous $23.3 Million 2.46%
% of portfolio
1.79%
Previous 0.33%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$172.58 - $196.48 $3.12 Million - $3.55 Million
-18,080 Reduced 13.45%
116,318 $22.7 Million
Q2 2024

Jul 19, 2024

BUY
$145.54 - $178.83 $3.94 Million - $4.84 Million
27,047 Added 25.19%
134,398 $23.3 Million
Q1 2024

May 08, 2024

SELL
$165.67 - $199.94 $103,046 - $124,362
-622 Reduced 0.58%
107,351 $18.2 Million
Q4 2023

Feb 12, 2024

BUY
$151.44 - $200.09 $3.7 Million - $4.89 Million
24,415 Added 29.22%
107,973 $21.3 Million
Q3 2023

Nov 07, 2023

SELL
$167.14 - $192.77 $4.58 Million - $5.28 Million
-27,409 Reduced 24.7%
83,558 $14.5 Million
Q2 2023

Aug 11, 2023

SELL
$160.94 - $186.23 $2.14 Million - $2.48 Million
-13,300 Reduced 10.7%
110,967 $19.1 Million
Q1 2023

May 04, 2023

SELL
$145.48 - $175.02 $2.09 Million - $2.51 Million
-14,366 Reduced 10.36%
124,267 $20.7 Million
Q4 2022

Feb 06, 2023

BUY
$131.14 - $157.47 $18.2 Million - $21.8 Million
138,633 New
138,633 $20.3 Million
Q3 2018

Nov 07, 2018

SELL
$83.5 - $93.23 $941,128 - $1.05 Million
-11,271 Closed
0 $0
Q2 2018

Aug 13, 2018

SELL
$79.9 - $89.2 $16.2 Million - $18.1 Million
-202,464 Reduced 94.73%
11,271 $960,000
Q1 2018

May 10, 2018

SELL
$71.51 - $84.69 $2.54 Million - $3 Million
-35,480 Reduced 14.24%
213,735 $22 Million
Q4 2017

Feb 09, 2018

BUY
$63.24 - $72.8 $2,213 - $2,548
35 Added 0.01%
249,215 $18 Million
Q3 2017

Oct 31, 2017

BUY
$59.73 - $65.4 $14.9 Million - $16.3 Million
249,180
249,180 $15.9 Million

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.2B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Cidel Asset Management Inc Portfolio

Follow Cidel Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cidel Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cidel Asset Management Inc with notifications on news.